188 related articles for article (PubMed ID: 11815437)
1. Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.
Zaidi SH; You XM; Ciura S; Husain M; Rabinovitch M
Circulation; 2002 Jan; 105(4):516-21. PubMed ID: 11815437
[TBL] [Abstract][Full Text] [Related]
2. Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis.
Zaidi SH; Hui CC; Cheah AY; You XM; Husain M; Rabinovitch M
J Clin Invest; 1999 Apr; 103(8):1211-9. PubMed ID: 10207173
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of the serine elastase inhibitor elafin protects against vein graft degeneration.
O'Blenes SB; Zaidi SH; Cheah AY; McIntyre B; Kaneda Y; Rabinovitch M
Circulation; 2000 Nov; 102(19 Suppl 3):III289-95. PubMed ID: 11082403
[TBL] [Abstract][Full Text] [Related]
5. Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.
Maruyama K; Ye CL; Woo M; Venkatacharya H; Lines LD; Silver MM; Rabinovitch M
Am J Physiol; 1991 Dec; 261(6 Pt 2):H1716-26. PubMed ID: 1836309
[TBL] [Abstract][Full Text] [Related]
6. Elafin-overexpressing mice have improved cardiac function after myocardial infarction.
Ohta K; Nakajima T; Cheah AY; Zaidi SH; Kaviani N; Dawood F; You XM; Liu P; Husain M; Rabinovitch M
Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H286-92. PubMed ID: 14693682
[TBL] [Abstract][Full Text] [Related]
7. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia.
Brusselmans K; Compernolle V; Tjwa M; Wiesener MS; Maxwell PH; Collen D; Carmeliet P
J Clin Invest; 2003 May; 111(10):1519-27. PubMed ID: 12750401
[TBL] [Abstract][Full Text] [Related]
8. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia.
Weissmann N; Manz D; Buchspies D; Keller S; Mehling T; Voswinckel R; Quanz K; Ghofrani HA; Schermuly RT; Fink L; Seeger W; Gassmann M; Grimminger F
Thromb Haemost; 2005 Sep; 94(3):630-8. PubMed ID: 16268482
[TBL] [Abstract][Full Text] [Related]
9. Endothelial ET(B) limits vascular remodelling and development of pulmonary hypertension during hypoxia.
Kelland NF; Bagnall AJ; Morecroft I; Gulliver-Sloan FH; Dempsie Y; Nilsen M; Yanagisawa M; Maclean MR; Kotelevtsev YV; Webb DJ
J Vasc Res; 2010; 47(1):16-22. PubMed ID: 19672104
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
Ogura S; Shimosawa T; Mu S; Sonobe T; Kawakami-Mori F; Wang H; Uetake Y; Yoshida K; Yatomi Y; Shirai M; Fujita T
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H155-62. PubMed ID: 23686713
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
12. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
[TBL] [Abstract][Full Text] [Related]
13. Arterial elastase activity after balloon angioplasty and effects of elafin, an elastase inhibitor.
Barolet AW; Nili N; Cheema A; Robinson R; Natarajan MK; O'Blenes S; Li J; Eskandarian MR; Sparkes J; Rabinovitch M; Strauss BH
Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1269-74. PubMed ID: 11498452
[TBL] [Abstract][Full Text] [Related]
14. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
[TBL] [Abstract][Full Text] [Related]
16. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
Nickel NP; Spiekerkoetter E; Gu M; Li CG; Li H; Kaschwich M; Diebold I; Hennigs JK; Kim KY; Miyagawa K; Wang L; Cao A; Sa S; Jiang X; Stockstill RW; Nicolls MR; Zamanian RT; Bland RD; Rabinovitch M
Am J Respir Crit Care Med; 2015 Jun; 191(11):1273-86. PubMed ID: 25853696
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide-dependent modulation of hypoxia-induced pulmonary vascular remodeling.
Chen YF; Feng JA; Li P; Xing D; Ambalavanan N; Oparil S
Life Sci; 2006 Aug; 79(14):1357-65. PubMed ID: 16714036
[TBL] [Abstract][Full Text] [Related]
18. Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats.
Nan X; Su S; Ma K; Ma X; Wang X; Zhaxi D; Ge R; Li Z; Lu D
J Ethnopharmacol; 2018 Apr; 216():175-183. PubMed ID: 29325918
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP.
Klinger JR; Petit RD; Curtin LA; Warburton RR; Wrenn DS; Steinhelper ME; Field LJ; Hill NS
J Appl Physiol (1985); 1993 Jul; 75(1):198-205. PubMed ID: 7690745
[TBL] [Abstract][Full Text] [Related]
20. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes.
Sallenave JM; Shulmann J; Crossley J; Jordana M; Gauldie J
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):733-41. PubMed ID: 7946401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
